Related references
Note: Only part of the references are listed.Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation
Simon McArthur et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Structural basis of ligand binding modes at the human formyl peptide receptor 2
Tong Chen et al.
NATURE COMMUNICATIONS (2020)
Dual modulation of formyl peptide receptor 2 by aspirin-triggered lipoxin contributes to its anti-inflammatory activity
Yunjun Ge et al.
FASEB JOURNAL (2020)
The Contribution of Chemoattractant GPCRs, Formylpeptide Receptors, to Inflammation and Cancer
Weiwei Liang et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure
Yoshikazu Asahina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization
Xiaofang Chen et al.
DIABETES (2019)
Illuminating G-Protein-Coupling Selectivity of GPCRs
Asuka Inoue et al.
CELL (2019)
Pro-Angiogenic Macrophage Phenotype to Promote Myocardial Repair
Bartolo Ferraro et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)
Monica de Gaetano et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment
Ricardo A. Garcia et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease
Eoin P. Brennan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis
Eoin P. Brennan et al.
DIABETES (2018)
Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
Monica de Gaetano et al.
FRONTIERS IN PHARMACOLOGY (2018)
Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949
Anna K. Stalder et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Formyl Peptide Receptor 2 Is Involved in Cardiac Repair After Myocardial Infarction Through Mobilization of Circulating Angiogenic Cells
Soon Chul Heo et al.
STEM CELLS (2017)
The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1
Katia M. Lima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Immune resolution mechanisms in inflammatory arthritis
Mauro Perretti et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
Cheng Xue Qin et al.
NATURE COMMUNICATIONS (2017)
Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (CAMP/PKA) pathway
Giorgio Mottola et al.
PLOS ONE (2017)
The common promoter polymorphism rs11666254 downregulates FPR2/ALX expression and increases risk of sepsis in patients with severe trauma
Han Zhang et al.
CRITICAL CARE (2017)
AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin
Emma Borgeson et al.
DIABETOLOGIA (2017)
Lipoxin A4 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition
Benedict Wu et al.
FASEB JOURNAL (2016)
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
Emma Boergeson et al.
CELL METABOLISM (2015)
Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation
Mauro Perretti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
FPR2/ALXR Agonists and the Resolution of Inflammation
Olivier Corminboeuf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Endogenous Annexin A1 Is a Novel Protective Determinant in Nonalcoholic Steatohepatitis in Mice
Irene Locatelli et al.
HEPATOLOGY (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis
Thomas Gobbetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
AMPKα1 Regulates Macrophage Skewing at the Time of Resolution of Inflammation during Skeletal Muscle Regeneration
Remi Mounier et al.
CELL METABOLISM (2013)
Cutting Edge: A Critical Role for the G Protein-Coupled Receptor mFPR2 in Airway Inflammation and Immune Responses
Keqiang Chen et al.
JOURNAL OF IMMUNOLOGY (2010)
Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation
Neil Dufton et al.
JOURNAL OF IMMUNOLOGY (2010)
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
R. D. Ye et al.
PHARMACOLOGICAL REVIEWS (2009)
The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice
Danielle G. Souza et al.
JOURNAL OF IMMUNOLOGY (2007)
Resolution of inflammation: The beginning programs the end
CN Serhan et al.
NATURE IMMUNOLOGY (2005)
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor
M Perretti et al.
NATURE MEDICINE (2002)
Share Paper
